Literature DB >> 15476204

A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis.

Leonid Padyukov1, Camilla Silva, Patrik Stolt, Lars Alfredsson, Lars Klareskog.   

Abstract

OBJECTIVE: The main genetic risk factor for rheumatoid arthritis (RA) is the shared epitope (SE) of HLA-DR, while smoking is an important environmental risk factor. We studied a potential gene-environment interaction between SE genes and smoking in the etiology of the 2 major subgroups of RA: rheumatoid factor (RF)-seropositive and RF-seronegative disease.
METHODS: A population-based case-control study involving incident cases of RF-seropositive and RF-seronegative RA (858 cases and 1,048 controls) was performed in Sweden. Cases and controls were classified according to their cigarette smoking status and HLA-DRB1 genotypes. The relative risk of developing RA was calculated for different gene/smoking combinations and was compared with the relative risk in never smokers without SE genes.
RESULTS: The relative risk of RF-seropositive RA was 2.8 (95% confidence interval [95% CI] 1.6-4.8) in never smokers with SE genes, 2.4 (95% CI 1.3-4.6) in current smokers without SE genes, and 7.5 (95% CI 4.2-13.1) in current smokers with SE genes. Smokers carrying double SE genes displayed a relative risk of RF-seropositive RA of 15.7 (95% CI 7.2-34.2). The interaction between smoking and SE genes was significant, as measured by the attributable proportion due to interaction, which was 0.4 (95% CI 0.2-0.7) for smoking and any SE, and 0.6 (95% CI 0.4-0.9) for smoking and a double SE. Neither smoking nor SE genes nor the combination of these factors increased the risk of developing RF-seronegative RA.
CONCLUSION: The disease risk of RF-seropositive RA associated with one of the classic genetic risk factors for immune-mediated diseases (the SE of HLA-DR) is strongly influenced by the presence of an environmental factor (smoking) in the population at risk. Copyright 2004 American College of Rheumatology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476204     DOI: 10.1002/art.20553

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  230 in total

1.  Uncovering a Shared Epitope-Activated Protein Citrullination Pathway.

Authors:  Vincent van Drongelen; Wahida H Ali; Joseph Holoshitz
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

Review 2.  Five years of GWAS discovery.

Authors:  Peter M Visscher; Matthew A Brown; Mark I McCarthy; Jian Yang
Journal:  Am J Hum Genet       Date:  2012-01-13       Impact factor: 11.025

3.  Inclusion of gene-gene and gene-environment interactions unlikely to dramatically improve risk prediction for complex diseases.

Authors:  Hugues Aschard; Jinbo Chen; Marilyn C Cornelis; Lori B Chibnik; Elizabeth W Karlson; Peter Kraft
Journal:  Am J Hum Genet       Date:  2012-05-24       Impact factor: 11.025

4.  Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis.

Authors:  Diane van der Woude; Wendimagegn Ghidey Alemayehu; Willem Verduijn; René R P de Vries; Jeanine J Houwing-Duistermaat; Tom W J Huizinga; René E M Toes
Journal:  Nat Genet       Date:  2010-10       Impact factor: 38.330

5.  Associations of cigarette smoking with rheumatoid arthritis in African Americans.

Authors:  Ted R Mikuls; Harlan Sayles; Fang Yu; Tricia Levan; Karen A Gould; Geoffrey M Thiele; Doyt L Conn; Beth L Jonas; Leigh F Callahan; Edwin Smith; Richard Brasington; Larry W Moreland; Richard J Reynolds; S Louis Bridges
Journal:  Arthritis Rheum       Date:  2010-12

Review 6.  The genomic landscape of human immune-mediated diseases.

Authors:  Xin Wu; Haiyan Chen; Huji Xu
Journal:  J Hum Genet       Date:  2015-08-20       Impact factor: 3.172

7.  Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history.

Authors:  Jeffrey A Sparks; Chia-Yen Chen; Xia Jiang; Johan Askling; Linda T Hiraki; Susan Malspeis; Lars Klareskog; Lars Alfredsson; Karen H Costenbader; Elizabeth W Karlson
Journal:  Ann Rheum Dis       Date:  2014-03-31       Impact factor: 19.103

8.  Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis.

Authors:  Maria Seddighzadeh; Marina Korotkova; Henrik Källberg; Bo Ding; Nina Daha; Fina A S Kurreeman; Rene E M Toes; Tom W Huizinga; Anca I Catrina; Lars Alfredsson; Lars Klareskog; Leonid Padyukov
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

Review 9.  Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis.

Authors:  V Michael Holers
Journal:  Curr Opin Immunol       Date:  2013-11-08       Impact factor: 7.486

10.  HLA-Cw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: A prospective case series.

Authors:  Ragna H Thorleifsdottir; Sigrun L Sigurdardottir; Bardur Sigurgeirsson; Jon H Olafsson; Hannes Petersen; Martin I Sigurdsson; Johann E Gudjonsson; Andrew Johnston; Helgi Valdimarsson
Journal:  J Am Acad Dermatol       Date:  2016-08-09       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.